Physician

Natalie Roney, M.D.

According to 2025 Medicare claims, Natalie Roney, M.D. (NPI: 1073622239) practices dermatology in the Binghamton, NY market, with the plurality of this provider's patient population coming from Broome, NY. This provider's primary affiliated billing organization is NEW SEASON DERMATOLOGY, PLLC (NPI: 1992215180; TIN: 822262775) and primary practice location at 13790-1308.

Roney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 483 traditional Medicare patients, billed 3,197 HCPCS/CPT codes, and received $122,192 in Medicare payments. The top billing code was 11102 (Biopsy of related skin growth, first growth). Part D data shows 1,133 prescription claims across 394 beneficiaries totaling $301,583 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 25 records totaling $421. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $133,302 and ending at $301,583. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$72K$144K2015 Medicare payment: $101,307 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $96,166 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $94,313 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $86,928 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $82,954 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $64,955 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $110,703 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $143,773 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $127,928 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $122,192 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156083,880$101,307
20166384,076$96,166
20176203,133$94,313
20185842,781$86,928
20195473,139$82,954
20204832,504$64,955
20214282,720$110,703
20224353,130$143,773
20234252,989$127,928
20244833,197$122,192

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$176K$352K2015 Drug cost: $133,302 (USD; Tot_Drug_Cst)2016 Drug cost: $235,912 (USD; Tot_Drug_Cst)2017 Drug cost: $352,086 (USD; Tot_Drug_Cst)2018 Drug cost: $250,258 (USD; Tot_Drug_Cst)2019 Drug cost: $229,713 (USD; Tot_Drug_Cst)2020 Drug cost: $352,212 (USD; Tot_Drug_Cst)2021 Drug cost: $296,260 (USD; Tot_Drug_Cst)2022 Drug cost: $128,281 (USD; Tot_Drug_Cst)2023 Drug cost: $196,775 (USD; Tot_Drug_Cst)2024 Drug cost: $301,583 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015383964$133,302
20163871,085$235,912
20173521,029$352,086
20183831,077$250,258
20193651,065$229,713
2020351942$352,212
2021320870$296,260
2022303831$128,281
2023345954$196,775
20243941,133$301,583

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
11102Biopsy of related skin growth, first growth257364$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more342478$60
11103Biopsy of related skin growth, each additional growth153373$36
17000Destruction of precancer skin growth, 1 growth198316$33
17003Destruction of precancer skin growth, 2-14 growths1501,068$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab14602$83,305
PimecrolimusPimecrolimus14389$3,301
TacrolimusTacrolimus34969$3,183
FluocinonideFluocinonide501,478$2,814
KetoconazoleKetoconazole1574,796$2,804

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$421Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Natalie Roney, M.D.?

Tedicare shows public-source Medicare data for Natalie Roney, M.D. (NPI 1073622239), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Natalie Roney, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Natalie Roney, M.D.?

Natalie Roney, M.D. is linked to NEW SEASON DERMATOLOGY, PLLC (billing NPI 1992215180) in the available physician profile data.

Does Natalie Roney, M.D. have Open Payments data?

Natalie Roney, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.